Stay updated on TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A footer “Revision” label was updated from v3.5.2 to v3.5.3, indicating a minor site or build version change rather than an update to the clinical study record.
    Difference
    0.1%
    Check dated 2026-04-25T05:24:44.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T23:59:49.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision tag updated: v3.5.0 added and v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-20T01:29:19.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page revision updated from v3.4.2 to v3.4.3. No user-visible changes to the study information or layout.
    Difference
    0.1%
    Check dated 2026-03-05T18:40:25.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.2. The previous Revision: v3.4.1 tag has been removed.
    Difference
    0.1%
    Check dated 2026-02-12T01:58:19.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page shows a minor metadata update from Revision: v3.4.0 to v3.4.1, with no changes to study content or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:25:40.000Z thumbnail image

Stay in the know with updates to TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.